We're hiring a Manager, Analytical Genetics to support growing efforts in large-scale proteomics at the RGC. Are you interested in applying machine learning to develop prediction models for age-related diseases? Apply below!
careers.regeneron.com/en/job… via @regeneron
With ~1M exomes sequenced, we published the largest set of human protein-coding variation to date today in @Nature. RGC-ME data contains genetic variation from individuals of African, American, South and East Asian and Middle Eastern ancestry.
We are still looking for a statistical geneticist to help drive our efforts in rare diseases! Reach out or apply at the link below if interested! careers.regeneron.com/NzJTjL…
Very excited to share our paper on genetics of the MCPS. Before you dive in a key point to highlight : from 1998-2004 our @UIME_UNAM & @Oxford_NDPH colleagues had the vision to conceive the study, and then visit >100,000 houses in Mexico City to recruit 150,000 participants 🤯
Hispanic/Latino individuals are represented in <1% of #GenomicResearch. To reduce this diversity gap, the Mexico City Prospective Study (MCPS) research team conducted the most extensive sequencing study in individuals of non-European ancestry to date. #RGCResearch
Congratulations to our very own, @joellembatchou, Ph.D., Manager of Statistical Genetics, as she was recognized as one of @FierceHealth and @FierceMedTech's rising stars in health tech! Join us in giving her a round of applause 👏 and read more about her inspiring work.
It is increasingly obvious that the line between traditional meds and tech-enabled healthcare companies has been blurred. So this year, we’re highlighting 17 rising stars in the health tech world who are doing their part to further erase that line.
tinyurl.com/yts4pumb
Our team is hiring! Are you a statistical geneticist with an interest in rare disease genetics, family-based analyses, and/or working with sequence data from diverse and understudied populations across the globe? Reach out or click below to learn more careers.regeneron.com/l4~wCV…
Our recent genome-wide analysis shows that levels of the ACE2 receptor influence COVID-19 risk. A genetic variant near the ACE2 gene decreases levels of the SARS-CoV-2 gateway receptor by 37% and infection risk by 40%. Read more about our recent discovery in @NatureGenet.
Check it out! Our work on the exome sequencing and analysis of 450k UK Biobank participants is now out in @Nature. Huge thank you to everyone who made it happen!
A #LandMark achievement in the history of human #Genetics ! Scientists from @RegeneronDNA have uncovered hundreds of genes that contribute to different traits and diseases👏👏👏!
Thanks to all the authors for lighting up our #genome👍👍👍@jdbackman
Read our paper on the exome sequencing of 454,787 @uk_biobank participants, published in @Nature. Our scientists continue to push the boundaries of genomics. Their work lights up our genome!
Read our paper on the exome sequencing of 454,787 @uk_biobank participants, published in @Nature. Our scientists continue to push the boundaries of genomics. Their work lights up our genome!
I broke the rules and checked tweets... no 🍺? Great thread @gabecasis. For those who can't access the paper in Nature without a subscription, we're trying to fix it asap! Will update soon.
Check it out! Our work on the exome sequencing and analysis of 450k UK Biobank participants is now out in @Nature. Huge thank you to everyone who made it happen!
Read our paper on the exome sequencing of 454,787 @uk_biobank participants, published in @Nature. Our scientists continue to push the boundaries of genomics. Their work lights up our genome!